Type 2 Diabetes and insulin resistance are major health risks, the incidence of which is increasing in all parts of the world

BioKier is developing oral products designed to mimic the effects of malabsorptive gastric bypass surgery which is the most effective treatment for diabetes. In this way, BioKier intends to change the way diabetes is managed and improve the lives of millions of patients worldwide.

BioKier at 5th Annual World Congress of Food and Nutrition, Kaohsiung, Taiwan

Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients

BioKier has published an article summarizing our pre-clinical and clinical research: “Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients”.  The data validate BioKier’s approach to managing glucose using colon-targeted nutrients. This article was published in pear review journal: Functional Foods in Health and Disease. Below you will find link to the article: http://ffhdj.com/index.php/ffhd/article/view/283/574.

What Is BioKier?

BioKier is a clinical-stage company developing oral products for the management of lipids and glucose that can be commercialized via 505(b)2 NDA path. These products are designed to mimic bariatric-metabolic surgery which is known to resolve diabetes and improve cardiometabolic health. Completed clinical trials show that BioKier’s approach improves gut hormone secretion and regulation of glucose and lipids.

BioKier's Partners

BioKier, Inc. has created a network of partnerships with experts in pharmaceutical development, medical treatment, business strategy, law, and laboratory services. This allows BioKier to utilize specialized guidance and advice at every step of the development process.

Recent News

Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients

BioKier has published an article summarizing our pre-clinical and clinical research: “Colonic delivery of nutrients for management of blood glucose in type 2 diabetes patients”.  The data validate BioKier’s approach to managing glucose using colon-targeted nutrients. This article was published in pear review journal: Functional Foods in Health and Disease. Below you will find link to the article: http://ffhdj.com/index.php/ffhd/article/view/283/574.
Read More


5th Annual World Congress of Food and Nutrition, Kaohsiung, Taiwan

Dr. George Szewczyk, presented at the 5th Annual World Congress of Food and Nutrition, held November 18-20, 2016, at The Conference Venue – Kaohsiung Exhibition Center in Kaohsiung, Taiwan.
Read More


Target Controlled Delivery of a Small Molecule to the Colon

Dr. Jennifer Law of Encap Drug Delivery, A Division of Capsugel, Livingston, West Lothian, Scotland, United Kingdom…
Read More

Contact Us!